SCHEMBL10705558

SCHEMBL10705558

CCCC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 9/20 0.52
▸ PGR P06401 8/20 0.52
▸ CYP3A4 P08684 6/20 0.52
▸ LMNA P02545 5/20 0.52
▸ AR P10275 5/20 0.52
▸ NPSR1 Q6W5P4 2/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ ALDH1A1 P00352 2/20 0.52
▸ CHRM2 P08172 2/20 0.52
▸ NR3C2 P08235 2/20 0.52
▸ ABCC4 O15439 1/20 0.52
▸ ABCB11 O95342 1/20 0.52
▸ ESR1 P03372 1/20 0.52
▸ SHBG P04278 1/20 0.52
▸ CHRM1 P11229 1/20 0.52
▸ HRH2 P25021 1/20 0.52
▸ AKR1C3 P42330 1/20 0.52
▸ AKR1C2 P52895 1/20 0.52
▸ AKR1C1 Q04828 1/20 0.52
▸ ESR2 Q92731 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10703743 0.96 NR3C1 (0.53) NR3C1PGRCYP3A4LMNAAR
SCHEMBL10706361 0.94 CYP3A4 (0.56) NR3C1PGRCYP3A4LMNAAR
SCHEMBL10703144 0.93 NR3C1 (0.54) NR3C1PGRCYP3A4LMNAAR
SCHEMBL10704998 0.89 NR3C1 (0.65) NR3C1PGRCYP3A4LMNAAR
SCHEMBL10707423 0.85 NR3C1 (0.59) NR3C1PGRCYP3A4LMNAAR
SCHEMBL11800122 0.84 CYP3A4 (0.55) NR3C1PGRCYP3A4LMNAAR
SCHEMBL11799756 0.84 CYP3A4 (0.55) NR3C1PGRCYP3A4LMNAAR
SCHEMBL11800114 0.84 CYP3A4 (0.55) NR3C1PGRCYP3A4LMNAAR
SCHEMBL11799760 0.84 CYP3A4 (0.55) NR3C1PGRCYP3A4LMNAAR
SCHEMBL10703509 0.84 NR3C1 (0.52) NR3C1PGRCYP3A4LMNAAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0153270-B1 1-ALPHA, 2-ALPHA-METHYLENE-6-METHYLENE AND 6-ALPHA-METHYL PREGNENES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SCHERING AKTIENGESELLSCHAFT (DE) 1988-07-27 — — EP claimed
EP-0153270-B1 1-ALPHA, 2-ALPHA-METHYLENE-6-METHYLENE AND 6-ALPHA-METHYL PREGNENES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SCHERING AKTIENGESELLSCHAFT (DE) 1988-07-27 — — EP disclosed
US-4670427-A ANTIANDROGENS SCHERING AKTIENGESELLSCHAFT (DE) 1987-06-02 — — US disclosed
EP-0153270-A2 1-Alpha, 2-alpha-methylene-6-methylene and 6-alpha-methyl pregnenes, process for their preparation and pharmaceutical compositions containing them SCHERING AKTIENGESELLSCHAFT (DE) 1985-08-28 — — EP disclosed
Send feedback